ANTARES PHARMA, INC. Insider Trading for April 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANTARES PHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ANTARES PHARMA, INC. for April 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 12 2017 | ATRS | ANTARES PHARMA, IN ... | SAMSON MARVIN | Director | Gift | G | 2.80 | 50,000 | 140,000 | 52,778 | 102.8 K to 52.8 K (-48.65 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.65 | 3,000 | 4,950 | 0 | |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Option Exercise | M | 1.65 | 37,000 | 61,050 | 3,000 | |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 3.00 | 3,000 | 9,000 | 890,002 | 893 K to 890 K (-0.34 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.65 | 3,000 | 4,950 | 893,002 | 890 K to 893 K (+0.34 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Sell | S | 3.00 | 37,000 | 111,070 | 890,002 | 927 K to 890 K (-3.99 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | APPLE ROBERT F | President & CEO | Buy | M | 1.65 | 37,000 | 61,050 | 927,002 | 890 K to 927 K (+4.16 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.65 | 21,762 | 35,907 | 0 | |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Option Exercise | M | 1.65 | 20,000 | 33,000 | 21,762 | |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.90 | 21,762 | 63,112 | 218,885 | 240.6 K to 218.9 K (-9.04 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.65 | 21,762 | 35,907 | 240,647 | 218.9 K to 240.6 K (+9.94 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Sell | S | 2.88 | 20,000 | 57,570 | 218,885 | 238.9 K to 218.9 K (-8.37 %) |
| Apr 05 2017 | ATRS | ANTARES PHARMA, IN ... | JACOB LEONARD S | Director | Buy | M | 1.65 | 20,000 | 33,000 | 238,885 | 218.9 K to 238.9 K (+9.14 %) |
| Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Option Exercise | M | 1.65 | 30,000 | 49,500 | 0 | |
| Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GONELLA JACQUES | Director | Buy | M | 1.65 | 30,000 | 49,500 | 12,056,413 | 12 M to 12.1 M (+0.25 %) |
| Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Option Exercise | M | 1.65 | 30,000 | 49,500 | 0 | |
| Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Sell | S | 2.91 | 30,000 | 87,276 | 160,213 | 190.2 K to 160.2 K (-15.77 %) |
| Apr 04 2017 | ATRS | ANTARES PHARMA, IN ... | GARRITY THOMAS J | Director | Buy | M | 1.65 | 30,000 | 49,500 | 190,213 | 160.2 K to 190.2 K (+18.73 %) |